Cloud DX Signs Record-Breaking 20th Contract, on Pace to Double Sales in 2023
News in SummaryWestern Canadian primary care group awards a new Remote Patient Monitoring (RPM) contract to Cloud DX after a...
Staff
Odyssey Unveils Rebrand of Eating Disorder Outpatient Clinics to Support Strategic Vision and Accelerated Growth
Continuing to provide a full spectrum of eating disorder treatment, four Selah House Outpatient clinics have rebranded as Aster Springs...
MDaudit Enhances Industry Leading Billing Compliance and Revenue Integrity Platform with Groundbreaking AI Capabilities
Insights.ai and SmartScan.ai optimize compliance and revenue integrity by unlocking access to deeper, more meaningful insights and automating key external...
Emagine Solutions Technology Wins $1 Million in R&D Funding from the U.S. National Science Foundation
Latest fundraising effort to strengthen Emagine’s powerful suite of maternal health toolsTUCSON, Ariz.--(BUSINESS WIRE)--Emagine Solutions Technology has been awarded $1...
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
Private equity-owned ophthalmology group, EyeSouth Partners, adopts ALLY for each operating room within its Gainesville, Georgia and Boynton Beach, Florida...
Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery
SAN FRANCISCO, CA / ACCESSWIRE / July 24, 2023 / A recent peer-reviewed study published in the American Journal of...
Health Karma Group Announces a Strategic Partnership with RocketTools.io AI-Drive Creative Services
FORT LAUDERDALE, FL / ACCESSWIRE / July 24, 2023 / MediXall Group Inc. (OTC PINK:MDXL) ("MediXall"), an innovative virtual health...
Vytalize Health Launches Charitable Initiative to Relieve Medical Debt Burden
Initial donation to RIP Medical Debt will erase $2 million in debt for families living on Long Island, furthering Vytalize...
Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results
WALTHAM, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement,...
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or...
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™)ALBANY, N.Y. and...
BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population
Initial topline data from COVALENT-101 trial revealed 2 complete responses (CRs) out of 5 relapsed/refractory AML patients carrying menin-dependent mutations...
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event
- Live moderated webcast with members of the GRI Bio management team on Thursday, July 27th at 1:00 PM ET...
MDbio – The Doctors BrandTM Publishes New Article About Artificial Intelligence in Healthcare
Beverly Hills, California, July 24, 2023 (GLOBE NEWSWIRE) -- MDbio – The Doctors BrandTM published a new article about artificial intelligence...
Lytus Technologies enters Fintech space with the launch of a new payment gateway in India
~Will invest 50 million dollars to expand their fintech service in India over the next 5 years~ Mumbai | New...
Capricor Therapeutics Announces Appointment of Philip J. Gotwals, Ph.D. to its Board of Directors
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of...
ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call
SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...
Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate
Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major...
Nanox Announces $30 Million Registered Direct Offering
NEVE ILAN, Israel, July 24, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative...